Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Reunion Neuroscience

    Client Virtual Booth

    REUNION NEUROSCIENCE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Reunion Neuroscience
    Canada Flag
    Country
    Country
    Canada
    Address
    Address
    30 Duncan Street Lower North Level Toronto, Ontario M5V 2C3
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://reunionneuro.com/
    Linkedin
    Linkedin
    https://linkedin.com/company/reunionneuro/
    Twitter
    Twitter
    https://twitter.com/ReunionNeuro

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Reunion Doses First Patient In Phase 2 Trial Of RE104 For Depression
    Reunion Doses First Patient In Phase 2 Trial Of RE104 For Depression

    https://www.globenewswire.com/news-release/2024/07/23/2917114/0/en/Reunion-Neuroscience-Inc-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-RE104-for-the-Treatment-of-Postpartum-Depression.html

    GLOBENEWSWIRE
    23 Jul 2024
    Share Share
    Reunion Publishes RE104 Preclinical Depression Disorder Potential
    Reunion Publishes RE104 Preclinical Depression Disorder Potential

    https://www.globenewswire.com/news-release/2024/05/20/2884773/0/en/Reunion-Neuroscience-Announces-Publication-of-Results-from-Early-Preclinical-Studies-Demonstrating-the-Potential-of-RE104-for-Development-in-Depressive-Disorders.html

    GLOBENEWSWIRE
    20 May 2024
    Share Share
    Reunion Neuroscience $103M Series A Led By MPM, Novo
    Reunion Neuroscience $103M Series A Led By MPM, Novo

    https://www.globenewswire.com/news-release/2024/05/02/2873978/0/en/Reunion-Neuroscience-Inc-Announces-103-Million-Series-A-Financing-Co-Led-by-MPM-BioImpact-and-Novo-Holdings.html

    GLOBENEWSWIRE
    02 May 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    farmak-a-s-m-2024-08-26

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search